Patents by Inventor Anthony R. Corless

Anthony R. Corless has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6846668
    Abstract: The microfabricated cell injector having an injection wall and a cell injection needle projecting from the wall for piercing cells suspended in a fluid. The needle is held within a housing defined by the internal surfaces of the microfabricated cell injector. The housing has an inlet for suspended cells to enter and an outlet for cells to exit via the cell injection needle. A cell propulsion device is provided for impelling cells towards the needle such that, in use, cells suspended in the fluid are impelled towards the injection wall by the injection needle.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: January 25, 2005
    Assignee: AstraZeneca AB
    Inventors: Andrew J. Garman, David J. Scanlon, John Dodgson, John Ea Shaw, David Brennan, Anthony R. Corless, Christopher M. Turner
  • Publication number: 20040106189
    Abstract: The invention relates to an apparatus for and method of introducing a substance into an object, particularly into a cell or cellular material. In a preferred arrangement apparatus receives the cell and preferably locates it between first and second electrodes and applies a voltage pulse to cause a disruption in the cell wall. This causes the cell to become permeable. The substance may then be introduced, for example under a fluid pressure. Cells may then be inspected and sorted into transfected and non-transfected types. This may be achieved automatically, for example by using electrophoresis.
    Type: Application
    Filed: November 10, 2003
    Publication date: June 3, 2004
    Applicant: AstraZeneca AB
    Inventors: John Dodgson, Anthony R. Corless
  • Patent number: 6653136
    Abstract: The invention relates to an apparatus for and method of introducing a substance into an object, particularly into a cell or cellular material. In a preferred arrangement apparatus receives the cell and preferably locates it between first and second electrodes and applies a voltage pulse to cause a disruption in the cell wall. This causes the cell to become permeable. The substance may then be introduced, for example under a fluid pressure. Cells may then be inspected and sorted into transfected and non-transfected types. This may be achieved automatically, for example by using electrophoresis.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: November 25, 2003
    Assignee: Astrazeneca AB
    Inventors: John Dodgson, Anthony R Corless
  • Patent number: 5514857
    Abstract: An access control system for a public transport system comprises, at each entrance/exit location (1) of the transport system, at least one entrance gate (12) provided with a ticket reader (8), at least one exit gate (20) provided with a ticket reader (16), a ticket issuing machine (22) and a local data processor (10) with which the other items communicate. The local processors (10) communicate via a central processor (14). The tickets bear unique identification codes which are stored, upon issue, in the local processors (10) at the location (1) at which they are valid for entry. Upon entry using a ticket the relevant code is cancelled at all locations and then it is stored again in the local processors (10) at those locations (1) at which it is valid for exit. Upon exit using a ticket the relevant code is cancelled at all locations. If entry or exit is attempted at a location (1) at which the relevant code is not stored, the relevant gate (12 or 20) is barred.
    Type: Grant
    Filed: December 27, 1994
    Date of Patent: May 7, 1996
    Assignee: Central Research Laboratories Limited
    Inventor: Anthony R. Corless